NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in NextCure, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q3 2024
- Shares held
- 16.0M
- +170.4K (+1.1%) vs. Q3 2024
- Total value
- $13.1M
- −$8.60M (−39.6%) vs. Q3 2024
- New holders
- 8
- 6 more added
- Sold out
- 6
- 13 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 252 | $194 | 0.00% | −5,138−95.3% | Reduced |
| BNP Paribas Arbitrage, SA | 385 | $297 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 658 | $508 | 0.00% | +658 | New |
| JPMorgan Chase & Co | 805 | $621 | 0.00% | −2−0.2% | Reduced |
| Advisor Group Holdings, Inc. | 1,191 | $917 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,202 | $3.24K | 0.00% | −1,264−23.1% | Reduced |
| XTX Topco Ltd | 13,577 | $10.5K | 0.00% | +13,577 | New |
| HSBC Holdings PLC | 17,363 | $13.7K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 20,198 | $15.6K | 0.00% | +9,424+87.5% | Added |
| LPL Financial LLC | 20,500 | $15.8K | 0.00% | −6,500−24.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 21,800 | $16.8K | 0.00% | −2,000−8.4% | Reduced |
| Virtu Financial LLC | 22,951 | $18.0K | 0.00% | +22,951 | New |
| Velan Capital Investment Management LP | 25,000 | $19.3K | 0.02% | +25,000 | New |
| Ieq Capital, LLC | 37,342 | $28.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 42,517 | $32.8K | 0.00% | −29,602−41.0% | Reduced |
| Northern Trust Corp | 47,493 | $36.6K | 0.00% | −69−0.1% | Reduced |
| Susquehanna International Group, LLP | 48,186 | $37.2K | 0.00% | +48,186 | New |
| Marquette Asset Management, LLC | 58,259 | $44.9K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 65,392 | $50.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 67,518 | $52.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,600 | $52.1K | 0.00% | −3,000−4.2% | Reduced |
| Citadel Advisors LLC | 78,678 | $60.7K | 0.00% | +22,724+40.6% | Added |
| Dimensional Fund Advisors LP | 85,853 | $66.2K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 104,000 | $80.2K | 0.00% | +4,000+4.0% | Added |
| Hudson Bay Capital Management LP | 107,672 | $83.0K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 120,012 | $92.5K | 0.02% | −10.0% | Reduced |
| Sio Capital Management, LLC | 130,000 | $100.2K | 0.03% | 00.0% | Unchanged |
| Macquarie Group Ltd | 150,000 | $116.0K | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 185,936 | $143.4K | 0.01% | −370,169−66.6% | Reduced |
| Geode Capital Management, LLC | 233,914 | $180.4K | 0.00% | +10,173+4.5% | Added |
| Cardiff Park Advisors, LLC | 262,000 | $202.0K | 0.02% | 00.0% | Unchanged |
| BML Capital Management, LLC | 273,536 | $210.9K | 0.13% | −2,929−1.1% | Reduced |
| Federated Hermes, Inc. | 315,180 | $243.0K | 0.00% | −6,347−2.0% | Reduced |
| Peapod Lane Capital LLC | 403,698 | $311.3K | 0.31% | +403,698 | New |
| Acadian Asset Management LLC | 488,440 | $375.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 519,300 | $400.4K | 0.00% | +113,300+27.9% | Added |
| Cable Car Capital LLC | 615,878 | $474.8K | 0.04% | 00.0% | Unchanged |
| Tang Capital Management LLC | 700,000 | $539.7K | 0.04% | +47,614+7.3% | Added |
| BlackRock, Inc. | 727,579 | $561.0K | 0.00% | −2,257−0.3% | Reduced |
| Vanguard Group Inc | 987,324 | $761.2K | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,141,200 | $879.9K | 0.02% | 00.0% | Unchanged |
| Citigroup Inc | 1,389,040 | $1.07M | 0.00% | +1,389,040 | New |
| Affinity Asset Advisors, LLC | 2,302,598 | $1.78M | 0.28% | 00.0% | Unchanged |
| Pfizer Inc | 1,458,550 | $1.89M | 0.07% | +1,458,550 | New |
| Sofinnova Investments, Inc. | 2,671,856 | $2.06M | 0.15% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −2,500,000−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −342,592−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −85,308−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −21,247−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −10,044−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |